united therapeutics glp-1 receptor agonist A schematic overview of agonists: classification, drug At the 2025 European Academy
Description
J.BenoitS
Obesity (Silver Spring) 2015;23:20752082
Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, et al
3 Nutrient deficiencies are a higher risk for those taking GLP-1 agonists because of decreased appetite and reduced food intake
